256840.KQ Overview

Company Profile

Related stocks

003850.KS • South Korea

Boryung

8,610 KRW

525.24M USD 1Y +0.2%

068760.KQ • South Korea

Celltrionph

38,800 KRW

1.28B USD 1Y -27.1%

195940.KQ • South Korea

HK inno.N

39,700 KRW

839.31M USD 1Y -13.3%

006280.KS • South Korea

GC Biopharma Corp.

129,400 KRW

1.1B USD 1Y -2.2%

009420.KS • South Korea

HANALL BIOPHARMA

44,000 KRW

1.67B USD 1Y +26.4%

185750.KS • South Korea

CHONGKUNDANG

65,900 KRW

647.98M USD 1Y -19.9%

BLISSGVS.BO • India

BLISS GVS PHARMA LTD.

644.55 INR

708.16M USD 1Y +341.4%

MOREPENLAB.NS • India

MOREPEN LAB. LTD

129.55 INR

733.49M USD 1Y +170.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

South Korea

Region

Asia-Pacific

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

72.0% p.a.

Max Drawdown (5Y)

-93.4%

Sharpe Ratio (5Y)

-0.49

Beta Factor

1.07

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (72.0% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -96.3% in the extended horizon.